尼沃卢马布治疗复发性和耐火性古典霍奇金淋巴瘤:回顾性单中心分析
Magdalena Witkowska1,2, Mikołaj Malicki3, Weronika Marcinkowska3
1Department of Hematology, Medical University of Lodz, Lodz, Poland.
Leukemia research reports
|July 17, 2025
概括
尼沃卢马布对霍奇金淋巴瘤 (HL) 患者有希望,实现了高初始响应率. 然而,长期的疗效和副作用,如复发和自身免疫并发症,需要在更大的研究中进一步调查.
科学领域:
- 在瘤学瘤学.
- 血液学 血液学 血液学
- 免疫治疗是一种免疫疗法.
背景情况:
- 霍奇金淋巴瘤 (HL) 治疗已经进步,用联合化疗 (多克索鲁比,白素,维布拉斯,达卡巴 - ABVD) 和辐射产生高生存率.
- 尽管可治愈,但ABVD治疗具有显著的长期副作用,需要对替代疗法的持续研究.
- 免疫检查点抑制剂,如nivolumab,为复发性或耐火性HL患者提供治疗潜力.
研究的目的:
- 评估尼沃卢马布在复发性或耐火性霍奇金淋巴瘤患者的长期疗效和安全性.
- 评估完整反应 (CR) 率,并确定复发和治疗相关并发症的模式.
主要方法:
- 追溯性研究分析了10名患有复发或耐火霍奇金淋巴瘤的患者队列,这些患者接受了nivolumab治疗.
- 长期跟踪监测治疗反应,疾病复发和不良事件.
主要成果:
- 在初始治疗阶段观察到高完全响应率 (CR).
- 在长期观察期间,10名患者中有5名患有疾病复发.
- 三名患者出现了因尼沃卢马布治疗而导致的自身免疫并发症.
结论:
- 尼沃卢马布在复发性/耐药性霍奇金淋巴瘤中显示出显著的初始疗效.
- 长期结果仍然令人担忧,很大一部分患者复发.
- 自身免疫性副作用是一个值得注意的并发症,需要仔细管理和进一步研究.
相关概念视频
02:56Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
01:27Tumor Immunotherapy
664
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
664
01:30Cancer Vaccines
517
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
517
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
01:21Cancer Survival Analysis
456
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
456